Fig. 4From: A subgroup of microRNAs defines PTEN-deficient, triple-negative breast cancer patients with poorest prognosis and alterations in RB1, MYC, and Wnt signalingRB1 pathway loss and high β-catenin, WNT, and PI3K signaling in the PTEN-low/miR-low subgroup of TNBC. a Heatmap of probability of pathway activity in 31 PTEN(−) TNBCs from training cohort. b t test of probability of pathway activity in 205 TNBC from training cohortBack to article page